NEWS

Recent research and activities at Ragon

Ragon Supports AIDS Walk 2014

Jun 04

Ragon Supports AIDS Walk 2014

Sunday, June 1 was a beautiful day for a walk… The 29th annual AIDS Walk Boston & 5K Run that is!     For the 18th year in a row, Team Ragon walked with the goal, not only of raising money, but also of raising awareness. As the 78 team members joined the thousands who […]

Read more
Employee Highlight: Dan Karel

Jun 01

Employee Highlight: Dan Karel

The expressed goal of the Ragon Insitute is lofty: to harness the immune system to prevent and cure human disease.  But behind every principal investigator publishing a new finding is a team of support staff enabling their research.  In the offices, administrative assistants, regulatory staff, and grant administrators manage the office, monitor funding, and ensure […]

Read more
Newsletter Vol 11: Ragon Celebrates Five Years, New Faculty Members

May 05

Newsletter Vol 11: Ragon Celebrates Five Years, New Faculty Members

  • posted by Ragon Institute
  • in newsletter
  • Comments Off on Newsletter Vol 11: Ragon Celebrates Five Years, New Faculty Members Comments

On February 28, the Ragon Institute celebrated five years of innovation and collaboration at the Walker Memorial on the Massachusetts Institute of Technology campus in Cambridge. Over 200 employees, friends and collaborators of the Institute gathered that evening to celebrate the ongoing commitment to progressive scientific discovery.   Since its establishment in 2009, the Ragon […]

Read more
Recipients of the 2014 Seed Grants Announced

Apr 21

Recipients of the 2014 Seed Grants Announced

Five principal investigators from the US and South Africa were awarded the first round of funding from the new Ragon TB Seed Grants.   One of the primary missions of the Ragon Institute is to provide a means for rapidly funding promising studies and emerging concepts in the field of HIV research. Since 2009, the […]

Read more
Ragon Team Receives Grant to Develop Engineered Cytotoxic T-Cells

Apr 10

Ragon Team Receives Grant to Develop Engineered Cytotoxic T-Cells

  • posted by Ragon Institute
  • in research
  • Comments Off on Ragon Team Receives Grant to Develop Engineered Cytotoxic T-Cells Comments

The Ragon Institute fosters an environment that breaks down silos between different fields of science. This has allowed Dr. Brad Jones, Ragon Institute post-doctoral fellow, to move forwards with an idea that takes an innovative technology developed in the laboratory of Dr. Darrell Irvine for the treatment of cancer, and to combine it with the […]

Read more
Employee Highlight: Alyssa Clark

Apr 07

Employee Highlight: Alyssa Clark

The expressed goal of the Ragon Insitute is lofty: to harness the immune system to prevent and cure human disease.  But behind every principal investigator publishing a new finding is a team of support staff enabling their research.  In the offices, administrative assistants, regulatory staff, and grant administrators manage the office, monitor funding, and ensure […]

Read more
Scully Receives Grant to Study Gender Differences in HIV Treatment

Apr 02

Scully Receives Grant to Study Gender Differences in HIV Treatment

  • posted by Ragon Institute
  • in research
  • Comments Off on Scully Receives Grant to Study Gender Differences in HIV Treatment Comments

Dr. Eileen Scully, M.D., Ph.D. of Massachusetts General Hospital and the Ragon Institute has been awarded funding from amfAR’s Research Consortium on HIV Eradication (ARCHE) program.   Founded in 1985, amfAR, one of the world’s leading nonprofit organizations, is dedicated to ending the global AIDS epidemic through innovative research. The ARCHE program was launched in […]

Read more
Ndhlovu Recognized by CAVD as Early Career Investigator

Mar 31

Ndhlovu Recognized by CAVD as Early Career Investigator

This month, Ragon Institute Instructor Zaza Ndhlovu, PhD was recognized by the Collaboration for AIDS Vaccine Discovery (CAVD) for significant contributions to research conducted within the CAVD.   The Collaboration for AIDS Vaccine Discovery (CAVD) is an international network of scientists and experts dedicated to designing a variety of novel HIV vaccine candidates and advancing […]

Read more
The Ragon Institute 2013 Annual Report

Mar 24

The Ragon Institute 2013 Annual Report

The 2013 Ragon Institute Annual Report is now available to view online or download! Learn about the Institute accomplishments during its fifth year!   2013 Ragon Institute Annual Report   [With the interactive plugin above, you can use the menu bar to share, download as a PDF, or expand to full screen.]   If you […]

Read more
Ragon Study Hones In On Mystery of HIV-Eliminating Vaccine Antibodies

Mar 20

Ragon Study Hones In On Mystery of HIV-Eliminating Vaccine Antibodies

  • posted by Ragon Institute
  • in research
  • Comments Off on Ragon Study Hones In On Mystery of HIV-Eliminating Vaccine Antibodies Comments

NIH Grantees Sharpen Understanding of Antibodies that May Cut Risk of HIV Infection   What immune response should a vaccine elicit to prevent HIV infection? Two studies bring scientists closer to answering this question by identifying previously unrecognized attributes of antibodies that appear to have reduced the risk of HIV infection in the clinical trial […]

Read more
Boucau Recieves Postdoc Recognition Award

Feb 20

Boucau Recieves Postdoc Recognition Award

Dr. Julie Boucau, postdoctoral fellow at Ragon, has been selected as a winner of the Postdoc Recognition Award by the Mass General Postdoc Association (MGPA).   The MGPA is an association which serves the MGH postdoctoral community, providing support for research and career related matters, and provides a platform for interaction of postdoctoral research fellows […]

Read more
Study identifies new stem cell-like population where HIV persists in spite of treatment

Jan 13

Study identifies new stem cell-like population where HIV persists in spite of treatment

  • posted by Ragon Institute
  • in breaking news
  • Comments Off on Study identifies new stem cell-like population where HIV persists in spite of treatment Comments

Recently discovered T memory stem cells may be a long-term viral reservoir, and potential targets for future treatment   Although antiviral therapy against HIV suppresses viral replication and allows infected individuals to live relatively healthy lives for many years, the virus persists in the body, and replication resumes if treatment is interrupted.  Now investigators from […]

Read more
Thobakgale Recognized by Wellcome and South African Academy of Science

Jan 06

Thobakgale Recognized by Wellcome and South African Academy of Science

Dr. Christina Thobakgale, senior lecturer and researcher at the Ragon-affiliated HIV Pathogenesis Programme (HPP) at the University of KwaZulu-Natal, South Africa, was recently recognized for two prestigious awards.   In November, Dr. Thobakgale was nominated into the South African Young Academy of Science (SAYAS). Every year, only 10 new members are selected from across South […]

Read more
Alter Receives Grant to Research New Strategies for Curing HIV Infection

Jan 02

Alter Receives Grant to Research New Strategies for Curing HIV Infection

  • posted by Ragon Institute
  • in research
  • Comments Off on Alter Receives Grant to Research New Strategies for Curing HIV Infection Comments

Dr. Galit Alter, Assistant Professor at the Ragon Institute, was awarded an NIH grant to identify new strategies to eliminate reservoir cells by a “shock and kill” approach.   In her grant application for which she was awarded $2 million in research funds, Dr. Alter proposes to test whether a class of monoclonal antibodies specific […]

Read more
Tully Awarded amfAR Fellowship

Dec 04

Tully Awarded amfAR Fellowship

Ragon Institute Research Fellow Dr. Damien Tully has been awarded the amfAR Mathilde Krim Fellowships in Basic Biomedical Research.   The Krim Fellowship program is an annual research initiative which supports young scientists seeking innovative solutions to HIV/AIDS.  This years six recipients, will each be awarded $150,000 over two years to support their research.   Dr. […]

Read more

Search